The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
Open accessAbstract
Cholangiocarcinomas (CCAs) are hepatobiliary cancers with features of cholangiocyte differentiation; they can be classified anatomically as intrahepatic (iCCA), perihilar (pCCA), or distal CCA (dCCA). These subtypes differ not only in their anatomic location but in epidemiology, origin, etiology, pathogenesis, and treatment. The incidence and mortality of iCCA has been increasing over the past 3 decades, and only a low percentage of patients survive until 5 y after diagnosis. Geographic variations in the incidence of CCA are related to variations in risk factors. Changes in oncogene and inflammatory signaling pathways, as well as genetic and epigenetic alterations and chromosome aberrations, have been shown to contribute to development of CCA. Furthermore, CCAs are surrounded by a dense stroma that contains many cancer-associated fibroblasts, which promotes their progression. We have gained a better understanding of the imaging characteristics of iCCAs and have developed advanced cytologic techniques to detect pCCAs. Patients with iCCAs are usually treated surgically, whereas liver transplantation following neoadjuvant chemoradiation is an option for a subset of patients with pCCAs. We review recent developments in our understanding of the epidemiology, pathogenesis, of CCA, along with advances in classification, diagnosis and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhang, K., Chen, D., Wang, X., Zhang, S., Wang, J., Gao, Y., & Yan, B. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12010385 · Cited by 29
RetractedKalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Valle, J., Wasan, H., Palmer, D. H., Cunningham, D., Anthoney, A., Maraveyas, A., Madhusudan, S., Iveson, T., Hughes, S., Pereira, S. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908721 · Cited by 4,406
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution
DeOliveira, M. L., Cunningham, S. C., Cameron, J. L., Kamangar, F., Winter, J. M., Lillemoe, K. D., Choti, M. A., Yeo, C. J., & Schulick, R. D. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000251366.62632.d3 · Cited by 1,300
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
Rohle, D., Popovici-Muller, J., Palaskas, N., Turcan, S., Grommes, C., Campos, C., Tsoi, J., Clark, O., Oldrini, B., Komisopoulou, E., et al. (2013) · Science · doi:10.1126/science.1236062 · Cited by 1,153
The Epidemiology of Cholangiocarcinoma
Shaib, Y., & El-Serag, H. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828889 · Cited by 1,132
Quante, M., Tu, S. P., Tomita, H., Gonda, T., Wang, S. S. W., Takashi, S., Baik, G. H., Shibata, W., DiPrete, B., Betz, K. S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.020 · Cited by 1,044
Increasing Incidence and Mortality of Primary Intrahepatic Cholangiocarcinoma in the United States
Patel, T. (2001) · Hepatology · doi:10.1053/jhep.2001.25087 · Cited by 1,010
Meng, F., Henson, R., Lang, M., Wehbe, H., Maheshwari, S., Mendell, J. T., Jiang, J., Schmittgen, T. D., & Patel, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.057 · Cited by 984
Risk factors for cholangiocarcinoma
Tyson, G. L., & El-Serag, H. B. (2011) · Hepatology · doi:10.1002/hep.24351 · Cited by 956
Endo, I., Gonen, M., Yopp, A. C., Dalal, K. M., Zhou, Q., Klimstra, D., D'Angelica, M., DeMatteo, R. P., Fong, Y., Schwartz, L., et al. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e318176c4d3 · Cited by 865
Drug development of MET inhibitors: targeting oncogene addiction and expedience
Comoglio, P. M., Giordano, S., & Trusolino, L. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2530 · Cited by 818
Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation
Wang, F., Travins, J., DeLaBarre, B., Penard-Lacronique, V., Schalm, S., Hansen, E., Straley, K., Kernytsky, A., Liu, W., Gliser, C., et al. (2013) · Science · doi:10.1126/science.1234769 · Cited by 804
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
Khan, S. A., Davidson, B. R., Goldin, R. D., Heaton, N., Karani, J., Pereira, S. P., Rosenberg, W. M. C., Tait, P., Taylor-Robinson, S. D., Thillainayagam, A. V., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301748 · Cited by 797
Clinical diagnosis and staging of cholangiocarcinoma
Blechacz, B., Komuta, M., Roskams, T., & Gores, G. J. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.131 · Cited by 747
Self-citationIdentification of Targetable FGFR Gene Fusions in Diverse Cancers
Wu, Y.-M., Su, F., Kalyana-Sundaram, S., Khazanov, N., Ateeq, B., Cao, X., Lonigro, R. J., Vats, P., Wang, R., Lin, S.-F., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0050 · Cited by 744
Borger, D. R., Tanabe, K. K., Fan, K. C., Lopez, H. U., Fantin, V. R., Straley, K. S., Schenkein, D. P., Hezel, A. F., Ancukiewicz, M., Liebman, H. M., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0386 · Cited by 728
Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas
Everhart, J. E., & Ruhl, C. E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.038 · Cited by 710
Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment†
Blechacz, B., & Gores, G. J. (2008) · Hepatology · doi:10.1002/hep.22310 · Cited by 681
Self-citationJaiswal, M., LaRusso, N. F., Burgart, L. J., & Gores, G. J. (2000) · PubMed · Cited by 653
Self-citationSleisenger and Fordtran's gastrointestinal and liver disease
Feldman, E. B. M., Friedman, L. S., & Brandt, L. J. (2015) · Elsevier eBooks · Cited by 636
Darwish Murad, S., Kim, W. R., Harnois, D. M., Douglas, D. D., Burton, J., Kulik, L. M., Botha, J. F., Mezrich, J. D., Chapman, W. C., Schwartz, J. J., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.008 · Cited by 597
Self-citationMammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
Song, H., Mak, K. K., Topol, L., Yun, K., Hu, J., Garrett, L., Chen, Y., Park, O., Chang, J., Simpson, R. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911409107 · Cited by 583
Sia, D., Hoshida, Y., Villanueva, A., Roayaie, S., Ferrer, J., Tabak, B., Peix, J., Sole, M., Tovar, V., Alsinet, C., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.001 · Cited by 575
Changing international trends in mortality rates for liver, biliary and pancreatic tumours
Khan, S. A., Taylor-Robinson, S. D., Toledano, M. B., Beck, A., Elliott, P., & Thomas, H. C. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00297-0 · Cited by 570
Andersen, J. B., Spee, B., Blechacz, B. R., Avital, I., Komuta, M., Barbour, A., Conner, E. A., Gillen, M. C., Roskams, T., Roberts, L. R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.005 · Cited by 552
Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study
Shaib, Y. H., El-Serag, H. B., Davila, J. A., Morgan, R., & McGlynn, K. A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.048 · Cited by 546
Cholangiocarcinoma: lessons from Thailand
Sripa, B., & Pairojkul, C. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282fbf9b3 · Cited by 531
Cholangiocarcinomas can originate from hepatocytes in mice
Fan, B., Malato, Y., Calvisi, D. F., Naqvi, S., Razumilava, N., Ribback, S., Gores, G. J., Dombrowski, F., Evert, M., Chen, X., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63212 · Cited by 529 · cited 2×
“Two recent studies in mice have shown that Notch activation is required for conversion of normal adult hepatocytes to biliary cells that are precursors of iCCA.(35,36) Overexpression of intracellular domain of the Notch 1 receptor in liver cells of mice resulted in formation of iCCAs.”
BackgroundSelf-citationPalmer, W. C., & Patel, T. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.022 · Cited by 517
Welzel, T. M., Graubard, B. I., El–Serag, H. B., Shaib, Y. H., Hsing, A. W., Davila, J. A., & McGlynn, K. A. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.05.020 · Cited by 514
Lee, K.-P., Lee, J.-H., Kim, T.-S., Kim, T.-H., Park, H.-D., Byun, J.-S., Kim, M.-C., Jeong, W.-I., Calvisi, D. F., Kim, J.-M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912203107 · Cited by 493
Worldwide trends in mortality from biliary tract malignancies
Patel, T. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-10 · Cited by 491
Exome sequencing of liver fluke–associated cholangiocarcinoma
Ong, C. K., Subimerb, C., Pairojkul, C., Wongkham, S., Cutcutache, I., Yu, W., McPherson, J. R., Allen, G. E., Ng, C. C. Y., Wong, B. H., et al. (2012) · Nature Genetics · doi:10.1038/ng.2273 · Cited by 486
Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma
Khan, S. A., Toledano, M. B., & Taylor-Robinson, S. D. (2008) · HPB · doi:10.1080/13651820801992641 · Cited by 431
Patel, A. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00744-3 · Cited by 425
Wang, P., Dong, Q., Zhang, C., Kuan, P.-F., Liu, Y., Jeck, W. R., Andersen, J. B., Jiang, W., Savich, G. L., Tan, T.-X., et al. (2013) · Oncogene · doi:10.1038/onc.2012.315 · Cited by 399 · cited 1×
“IDH1 and IDH2 mutations were associated significantly with increased levels of p53 and DNA hypermethylation.(76) Epigenetic changes associated with IDHmutations likely mediate their oncogenic effects.”
BackgroundWelzel, T. M., McGlynn, K. A., Hsing, A. W., O'Brien, T. R., & Pfeiffer, R. M. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj234 · Cited by 372
Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin
Komuta, M., Spee, B., Borght, S. V., De Vos, R., Verslype, C., Aerts, R., Yano, H., Suzuki, T., Matsuda, M., Fujii, H., et al. (2008) · Hepatology · doi:10.1002/hep.22238 · Cited by 363
Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes
Sekiya, S., & Suzuki, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63065 · Cited by 348
Pathological classification of intrahepatic cholangiocarcinoma based on a new concept
Nakanuma, Y. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i12.419 · Cited by 335
Komuta, M., Govaere, O., Vandecaveye, V., Akiba, J., Van Steenbergen, W., Verslype, C., Laleman, W., Pirenne, J., Aerts, R., Yano, H., et al. (2012) · Hepatology · doi:10.1002/hep.25595 · Cited by 333
Sørensen, H. T., Friis, S., Olsen, J. H., Thulstrup, A. M., Mellemkjær, L., Linet, M., Trichopoulos, D., Vilstrup, H., & Olsen, J. (1998) · Hepatology · doi:10.1002/hep.510280404 · Cited by 328
Nakamura, T., Matsumoto, K., Kiritoshi, A., Tano, Y., & Nakamura, T. (1997) · PubMed · Cited by 321
New staging system and a registry for perihilar cholangiocarcinoma
DeOliveira, M. L., Schulick, R. D., Nimura, Y., Rosen, C., Gores, G., Neuhaus, P., & Clavien, P.-A. (2011) · Hepatology · doi:10.1002/hep.24227 · Cited by 318
Self-citationClassification, Diagnosis, and Management of Cholangiocarcinoma
Razumilava, N., & Gores, G. J. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.09.009 · Cited by 312
Self-citationAdvanced Cytologic Techniques for the Detection of Malignant Pancreatobiliary Strictures
Moreno Luna, L. E., Kipp, B., Halling, K. C., Sebo, T. J., Kremers, W. K., Roberts, L. R., Barr Fritcher, E. G., Levy, M. J., & Gores, G. J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.021 · Cited by 312
Self-citationChoi, S.-B., Kim, K.-S., Choi, J.-Y., Park, S.-W., Choi, J.-S., Lee, W.-J., & Chung, J.-B. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0631-1 · Cited by 304
Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin
Komuta, M., Borght, S. V., Kojiro, M., Aerts, R., & Roskams, T. (2007) · Cited by 301
Rimola, J., Forner, A., Reig, M., Vilana, R., de Lope, C. R., Ayuso, C., & Bruix, J. (2009) · Hepatology · doi:10.1002/hep.23071 · Cited by 298
Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?
Khan, S. A., Emadossadaty, S., Ladep, N. G., Thomas, H. C., Elliott, P., Taylor-Robinson, S. D., & Toledano, M. B. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.11.015 · Cited by 290
Heimbach, J. K., Sanchez, W., Rosen, C. B., & Gores, G. J. (2011) · HPB · doi:10.1111/j.1477-2574.2011.00298.x · Cited by 288
Self-citationOxysterols are allosteric activators of the oncoprotein Smoothened
Nachtergaele, S., Mydock, L. K., Krishnan, K., Rammohan, J., Schlesinger, P. H., Covey, D. F., & Rohatgi, R. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.765 · Cited by 284
Baril, P., Gangeswaran, R., Mahon, P. C., Caulee, K., Kocher, H. M., Harada, T., Zhu, M., Kalthoff, H., Crnogorac-Jurcevic, T., & Lemoine, N. R. (2007) · Oncogene · doi:10.1038/sj.onc.1210009 · Cited by 275
Portal fibroblasts: Underappreciated mediators of biliary fibrosis†
Dranoff, J. A., & Wells, R. G. (2010) · Hepatology · doi:10.1002/hep.23405 · Cited by 273
Oishi, N., Kumar, M. R., Roessler, S., Ji, J., Forgues, M., Budhu, A., Zhao, X., Andersen, J. B., Ye, Q.-H., Jia, H.-L., et al. (2012) · Hepatology · doi:10.1002/hep.25890 · Cited by 260
Shaib, Y. H., El-Serag, H. B., Nooka, A. K., Thomas, M., Brown, T. D., Patt, Y. Z., & Hassan, M. M. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01104.x · Cited by 258
Hofmann, J. J., Zovein, A. C., Koh, H., Radtke, F., Weinmaster, G., & Iruela-Arispe, M. L. (2010) · Development · doi:10.1242/dev.052118 · Cited by 249
Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma
Kipp, B. R., Voss, J. S., Kerr, S. E., Barr Fritcher, E. G., Graham, R. P., Zhang, L., Highsmith, W. E., Zhang, J., Roberts, L. R., Gores, G. J., et al. (2012) · Human Pathology · doi:10.1016/j.humpath.2011.12.007 · Cited by 244
Self-citationFibroblast Activation Protein and Its Relationship to Clinical Outcome in Pancreatic Adenocarcinoma
Cohen, S. J., Alpaugh, R. K., Palazzo, I., Meropol, N. J., Rogatko, A., Xu, Z., Hoffman, J. P., Weiner, L. M., & Cheng, J. D. (2008) · Pancreas · doi:10.1097/mpa.0b013e31816618ce · Cited by 243
Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies
Sia, D., Tovar, V, Moeini, A., & Llovet, J. M. (2013) · Oncogene · doi:10.1038/onc.2012.617 · Cited by 235
Hepatocyte growth factor and the Met system as a mediator of tumor–stromal interactions
Matsumoto, K., & Nakamura, T. (2006) · International Journal of Cancer · doi:10.1002/ijc.21808 · Cited by 231
Isomoto, H., Kobayashi, S., Werneburg, N. W., Bronk, S. F., Guicciardi, M. E., Frank, D. A., & Gores, G. J. (2005) · Hepatology · doi:10.1002/hep.20966 · Cited by 227
Self-citationKobayashi, S., Werneburg, N. W., Bronk, S. F., Kaufmann, S. H., & Gores, G. J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.010 · Cited by 226
Self-citationThe role of microRNA expression pattern in human intrahepatic cholangiocarcinoma
Chen, L., Yan, H.-X., Yang, W., Hu, L., Yu, L.-X., Liu, Q., Li, L., Huang, D.-D., Ding, J., Shen, F., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.09.015 · Cited by 224
Sustained IL-6/STAT-3 Signaling in Cholangiocarcinoma Cells Due to SOCS-3 Epigenetic Silencing
Isomoto, H., Mott, J. L., Kobayashi, S., Werneburg, N. W., Bronk, S. F., Haan, S., & Gores, G. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.037 · Cited by 219
Self-citationTaniai, M., Grambihler, A., Higuchi, H., Werneburg, N., Bronk, S. F., Farrugia, D. J., Kaufmann, S. H., & Gores, G. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2770 · Cited by 218
Self-citationHepatitis B Virus Infection and Intrahepatic Cholangiocarcinoma in Korea: A Case-Control Study
Lee, T. Y., Lee, S. S., Jung, S. W., Jeon, S. H., Yun, S.-C., Oh, H.-C., Kwon, S., Lee, S. K., Seo, D. W., Kim, M.-H., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01796.x · Cited by 217
Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
Mertens, J. C., Fingas, C. D., Christensen, J. D., Smoot, R. L., Bronk, S. F., Werneburg, N. W., Gustafson, M. P., Dietz, A. B., Roberts, L. R., Sirica, A. E., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2130 · Cited by 212
Self-citationXu, X. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27282 · Cited by 207
Park, J., Tadlock, L., Gores, G. J., & Patel, T. (1999) · Hepatology · doi:10.1002/hep.510300522 · Cited by 206
Self-citationA Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas
Zender, S., Nickeleit, I., Wuestefeld, T., Sörensen, I., Dauch, D., Bozko, P., El-Khatib, M., Geffers, R., Bektas, H., Manns, M. P., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.019 · Cited by 200
Hong, J. C. (2011) · Archives of Surgery · doi:10.1001/archsurg.2011.116 · Cited by 196
Welzel, T. M., Mellemkjaer, L., Gloria, G., Sakoda, L. C., Hsing, A. W., Ghormli, L. E., Olsen, J. H., & McGlynn, K. A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22283 · Cited by 195
Yoon, J., Higuchi, H., Werneburg, N. W., Kaufmann, S. H., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32410 · Cited by 193
Self-citationKrasG12D and p53 Mutation Cause Primary Intrahepatic Cholangiocarcinoma
O'Dell, M. R., Li Huang, J., Whitney-Miller, C. L., Deshpande, V., Rothberg, P., Grose, V., Rossi, R. M., Zhu, A. X., Land, H., Bardeesy, N., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3596 · Cited by 192
McGlynn, K. A., Tarone, R. E., & El-Serag, H. B. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0811 · Cited by 190
The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma
Sirica, A. E. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.222 · Cited by 188
Modeling Pathogenesis of Primary Liver Cancer in Lineage-Specific Mouse Cell Types
Holczbauer, Á., Factor, V. M., Andersen, J. B., Marquardt, J. U., Kleiner, D. E., Raggi, C., Kitade, M., Seo, D., Akita, H., Durkin, M. E., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.03.013 · Cited by 181
Cadamuro, M., Nardo, G., Indraccolo, S., Dall'Olmo, L., Sambado, L., Moserle, L., Franceschet, I., Colledan, M., Massani, M., Stecca, T., et al. (2013) · Hepatology · doi:10.1002/hep.26384 · Cited by 175
MicroRNA-26a Promotes Cholangiocarcinoma Growth by Activating β-catenin
Zhang, J., Han, C., & Wu, T. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.045 · Cited by 173
Myofibroblast-derived PDGF-BB promotes hedgehog survival signaling in cholangiocarcinoma cells
Fingas, C. D., Bronk, S. F., Werneburg, N. W., Mott, J. L., Guicciardi, M. E., Cazanave, S. C., Mertens, J. C., Sirica, A. E., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.24588 · Cited by 163
Self-citationUtispan, K., Thuwajit, P., Abiko, Y., Charngkaew, K., Paupairoj, A., Chau‐in, S., & Thuwajit, C. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-13 · Cited by 151
Ohashi, K., Nakajima, Y., Kanehiro, H., Tsutsumi, M., Taki, J., Aomatsu, Y., Yoshimura, A., Ko, S., Kin, T., Yagura, K., et al. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90650-9 · Cited by 135
Enhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells
Yoon, J., Gwak, G., Lee, H.-S., Bronk, S. F., Werneburg, N. W., & Gores, G. J. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.07.016 · Cited by 132
Self-citationYang, H., Li, T. W. H., Peng, J. W., Tang, X., Ko, K. S., Xia, M., & Aller, M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.03.044 · Cited by 131
Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
Miyamoto, M., Ojima, H., Iwasaki, M., Shimizu, H., Kokubu, A., Hiraoka, N., Kosuge, T., Yoshikawa, D., Kono, T., Furukawa, H., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.199 · Cited by 129
Cardinale, V., Carpino, G., Reid, L., Gaudio, E., & Alvaro, D. (2012) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v4.i5.94 · Cited by 126
Meng, F., Yamagiwa, Y., Ueno, Y., & Patel, T. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.030 · Cited by 123
Descriptive Epidemiology of Cholangiocarcinoma and Clonorchiasis in Korea
Shin, H., Oh, J., Lim, M. K., Shin, A., Kong, H., Jung, K., Won, Y., Park, S., Park, S., & Hong, S. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.7.1011 · Cited by 122
Ohira, S., Sasaki, M., Harada, K., Sato, Y., Zen, Y., Isse, K., Kozaka, K., Ishikawa, A., Oda, K., Nimura, Y., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050204 · Cited by 120
Terada, T., Okada, Y., & Nakanuma, Y. (1996) · Hepatology · doi:10.1002/hep.510230608 · Cited by 117
Fritcher, E. G. B., Kipp, B. R., Voss, J. S., Clayton, A. C., Lindor, K. D., Halling, K. C., & Gores, G. J. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.272 · Cited by 112
Self-citationHepatic Stellate Cells May Relate to Progression of Intrahepatic Cholangiocarcinoma
Okabe, H., Beppu, T., Hayashi, H., Horino, K., Masuda, T., Komori, H., Ishikawa, S., Watanabe, M., Takamori, H., Iyama, K.-I., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0568-4 · Cited by 111
Genetic profiling of intrahepatic cholangiocarcinoma
Andersen, J. B., & Thorgeirsson, S. S. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283523c7e · Cited by 104
Sato, Y., Harada, K., Itatsu, K., Ikeda, H., Kakuda, Y., Shimomura, S., Ren, X. S., Yoneda, N., Sasaki, M., & Nakanuma, Y. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090747 · Cited by 101
Yoon, J., Canbay, A. E., Werneburg, N. W., Lee, S. P., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20125 · Cited by 100
Self-citationLeptin Enhances Cholangiocarcinoma Cell Growth
Fava, G., Alpini, G. D., Rychlicki, C., Saccomanno, S., DeMorrow, S., Trozzi, L., Candelaresi, C., Venter, J. K., Sario, A. D., Marzioni, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6682 · Cited by 99
Farazi, P. A., Zeisberg, M., Glickman, J. N., Zhang, Y., Kalluri, R., & DePinho, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4609 · Cited by 99
Prakobwong, S., Yongvanit, P., Hiraku, Y., Pairojkul, C., Sithithaworn, P., Pinlaor, P., & Pinlaor, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25266 · Cited by 98
Olaru, A., Ghiaur, G., Yamanaka, S., Luvsanjav, D., An, F., Popescu, I., Alexandrescu, S. T., Allen, S. E., Pawlik, T. M., Torbenson, M. S., et al. (2010) · Hepatology · doi:10.1002/hep.24591 · Cited by 98
Self-citationStaging cholangiocarcinoma by imaging studies
Vilgrain, V. (2008) · HPB · doi:10.1080/13651820801992617 · Cited by 98
Fava, G., Marucci, L., Glaser, S. S., Francis, H., Morrow, S. D., Benedetti, A., Alvaro, D., Venter, J. K., Meininger, C. J., Patel, T. C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1470 · Cited by 98
Fabris, L., Cadamuro, M., Moserle, L., Dziura, J. D., Cong, X., Sambado, L., Nardo, G., Sonzogni, A., Colledan, M., Furlanetto, A., et al. (2011) · Hepatology · doi:10.1002/hep.24466 · Cited by 86
Human Wisp1v, A Member of the Ccn Family, Is Associated With Invasive Cholangiocarcinoma
Tanaka, S., Sugimachi, K., 亀山, 敏., Maehara, S., Shirabe, K., Shimada, M., Wands, J. R., & Maehara, Y. (2003) · Hepatology · doi:10.1053/jhep.2003.50187 · Cited by 86
Sirica, A. E., Zhang, Z., Lai, G., Asano, T., Shen, X., Ward, D. J., Mahatme, A., & DeWitt, J. L. (2007) · Hepatology · doi:10.1002/hep.22088 · Cited by 85
p53 mutations in human cholangiocarcinoma: a review
Khan, S. A., Thomas, H. C., Toledano, M. B., Cox, I. J., & Taylor-Robinson, S. D. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01106.x · Cited by 82
Khatib, M. E., Kalnytska, A., Palagani, V., Kossatz-Boehlert, U., Manns, M. P., Malek, N. P., Wilkens, L., & Plentz, R. R. (2012) · Hepatology · doi:10.1002/hep.26147 · Cited by 81
Fritcher, E. G. B., Voss, J. S., Jenkins, S. M., Lingineni, R. K., Clayton, A. C., Roberts, L. R., Halling, K. C., Talwalkar, J. A., Gores, G. J., & Kipp, B. R. (2013) · Cancer Cytopathology · doi:10.1002/cncy.21331 · Cited by 78
Self-citationMicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer
Yamanaka, S., Olaru, A., An, F., Luvsanjav, D., Jin, Z., Agarwal, R., Tomuleasa, C., Popescu, I., Alexandrescu, S. T., Dima, S., et al. (2012) · Digestive and Liver Disease · doi:10.1016/j.dld.2012.02.016 · Cited by 78
IDH1 and IDH2: Not Your Typical Oncogenes
Reitman, Z. J., Parsons, D. W., & Yan, H. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.02.024 · Cited by 75
Hou, Y.-J., Dong, L., Tan, Y., Yang, G.-Z., Pan, Y., Li, Z., Tang, L., Wang, M., Wang, Q., & Wang, H. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.97 · Cited by 71
Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion
Leelawat, K., Leelawat, S., Narong, S., & Hongeng, S. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i10.1561 · Cited by 70
Menakongka, A. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i6.713 · Cited by 69
Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma
Wong, N., Li, L., Tsang, K. S., Lai, P. B. S., To, K., & Johnson, P. J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00269-6 · Cited by 68
Prognostic Value of Cirrhosis for Intrahepatic Cholangiocarcinoma After Surgical Treatment
Li, Y., Li, H., Lv, P., Liu, G., Li, X., Tian, B., & Chen, D. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1419-8 · Cited by 66
KRAS and PIK3CA but not BRAF genes are frequently mutated in Chinese cholangiocarcinoma patients
Xu, R., Sun, J. P., Zhang, S. R., Zhu, G. S., Li, L. B., Liao, Y. L., Xie, J. M., & Liao, W. J. (2010) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2010.06.009 · Cited by 63
Hepatic Resection in the Treatment of Hilar Cholangiocarcinoma
Nagorney, D. M., & Kendrick, M. L. (2006) · Advances in Surgery · doi:10.1016/j.yasu.2006.05.009 · Cited by 61
Obchoei, S., Weakley, S. M., Wongkham, S., Wongkham, C., Sawanyawisuth, K., Yao, Q. C., & Chen, C. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-102 · Cited by 58
Relation of hepatolithiasis to helminthic infestation
Huang, M., CHEN, C., Yen, C., Yang, J.-C., Yang, C., Yeh, Y., Chou, D., Yueh, S.-K., YANG, Y., & Nien, C. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03523.x · Cited by 57
Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Koo, S. H., Ihm, C. H., Kwon, K. C., Park, J. W., Kim, J., & Kong, G. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00460-5 · Cited by 54
Epithelial-Mesenchymal Transition Induced by Hepatitis C Virus Core Protein in Cholangiocarcinoma
Li, T., Li, D., Cheng, L., Wu, H., Gao, Z., Liu, Z., Jiang, W., Gao, Y., Tian, F., Zhao, L., et al. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0925-3 · Cited by 52
Molecular Mechanisms of Tamoxifen Therapy for Cholangiocarcinoma: Role of Calmodulin
Pawar, P., Ma, L., Byon, C. H., Liu, H., Ahn, E.-Y. E., Jhala, N. C., Arnoletti, J. P., McDonald, J. M., & Chen, Y. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1150 · Cited by 51
Targeting PDGFR ‐β in Cholangiocarcinoma
Fingas, C. D., Mertens, J. C., Razumilava, N., Bronk, S. F., Sirica, A. E., & Gores, G. J. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02687.x · Cited by 49
Self-citationLai, G., Radaeva, S., Nakamura, T., & Sirica, A. E. (2000) · Hepatology · doi:10.1053/jhep.2000.8108 · Cited by 47
Korita, P. V., Wakai, T., Ajioka, Y., Inoue, M., Takamura, M., Shirai, Y., & Hatakeyama, K. (2010) · PubMed · Cited by 46
Novel organotypic culture model of cholangiocarcinoma progression
Campbell, D. J. W., Dumur, C. I., Lamour, N. F., DeWitt, J. L., & Sirica, A. E. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01026.x · Cited by 44
Increased risk of death in thorotrast-exposed patients during the late follow-up period.
Kato, I., & Kido, C. (1987) · PubMed · Cited by 42
Mechanisms of oxysterol-induced disease: insights from the biliary system
Kuver, R. (2012) · Clinical Lipidology · doi:10.2217/clp.12.53 · Cited by 42
McKay, S. C., Unger, K., Pericleous, S., Stamp, G. W. H., Thomas, G. A., Hutchins, R., & Spalding, D. R. C. (2011) · HPB · doi:10.1111/j.1477-2574.2010.00286.x · Cited by 40
Tsuchiya, A., Kamimura, H., Tamura, Y., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.05.021 · Cited by 40
Sirica, A. E., Nathanson, M. H., Gores, G. J., & LaRusso, N. F. (2008) · Hepatology · doi:10.1002/hep.22623 · Cited by 38
Self-citationAnimal models of cholangiocarcinoma
Ko, K. S., Peng, J. W., & Yang, H. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835d6a3e · Cited by 19
Tumors of the Bile Ducts, Gallbladder, and Ampulla
Blechacz, B. R. A., & Gores, G. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00069-x · Cited by 15
Self-citationPlengsuriyakarn, T., Eursitthichai, V., Labbunruang, N., Na‐Bangchang, K., Tesana, S., Aumarm, W., Pongpradit, A., & Viyanant, V. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.1.087 · Cited by 14
Cited by
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
Cholangiocarcinoma — evolving concepts and therapeutic strategies
Ilyas, S. I., Khan, S. A., Hallemeier, C. L., Kelley, R. K., & Gores, G. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.157 · Cited by 1,626
Self-citationAbou-Alfa, G. K., Sahai, V., Hollebecque, A., Vaccaro, G., Melisi, D., Al-Rajabi, R., Paulson, A. S., Borad, M. J., Gallinson, D., Murphy, A. G., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30109-1 · Cited by 1,611
Banales, J. M., Cardinale, V., Carpino, G., Marzioni, M., Andersen, J. B., Invernizzi, P., Lind, G. E., Folseraas, T., Forbes, S. J., Fouassier, L., et al. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.51 · Cited by 1,376
Genomic spectra of biliary tract cancer
Nakamura, H., Arai, Y., Totoki, Y., Shirota, T., Elzawahry, A., Kato, M., Hama, N., Hosoda, F., Urushidate, T., Ohashi, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3375 · Cited by 1,284
Metadata
- Authors
- Ilyas, S. I., & Gores, G. J.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 145
- Issue
- 6
- Pages
- 1215-1229
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2028700227
- Cited by
- 1,307
- References
- 137
- FWCI
- 61.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.